Global Targeted-protein Degradation Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 73 pages | ID: GF4AA549BD52EN
LP Information

Abstracts

According to this study, the global Targeted-protein Degradation Therapeutics market size will reach US$ 2014 million by 2031.

Targeted protein degradation (TPD) has surfaced as a novel and innovative chemical tool and therapeutic modality. By co-opting protein degradation pathways, TPD facilitates complete removal of the protein molecules from within or outside the cell. While the pioneering Proteolysis-Targeting Chimera (PROTAC) technology and molecular glues hijack the ubiquitin-proteasome system, newer modalities co-opt autophagy or the endo-lysosomal pathway.

The Protein Degradation Therapy market has gained momentum as a promising approach in drug development. This innovative strategy aims to target disease-causing proteins by facilitating their degradation within cells. Proteins that contribute to diseases like cancer and neurodegenerative disorders can be selectively broken down using small molecules known as proteolysis-targeting chimeras (PROTACs) or other protein degraders. This approach offers advantages over traditional inhibition methods, potentially leading to more effective treatments with reduced side effects. As researchers delve into protein-protein interactions and cellular mechanisms, the Protein Degradation Therapy market is expanding, presenting opportunities to address previously challenging diseases and advance precision medicine. Clinical progress and continued research in this field are expected to shape the future of therapeutic interventions.

LPI (LP Information)' newest research report, the “Targeted-protein Degradation Therapeutics Industry Forecast” looks at past sales and reviews total world Targeted-protein Degradation Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted-protein Degradation Therapeutics sales for 2025 through 2031. With Targeted-protein Degradation Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted-protein Degradation Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Targeted-protein Degradation Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted-protein Degradation Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted-protein Degradation Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted-protein Degradation Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted-protein Degradation Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Targeted-protein Degradation Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• ARV-110
• ARV-471
• Other

Segmentation by Application:

• Cancer
• Neuroscience
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Arvinas
• Nurix Therapeutics
• Kymera Therapeutics
• C4 Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Targeted-protein Degradation Therapeutics Market Size (2020-2031)
  2.1.2 Targeted-protein Degradation Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Targeted-protein Degradation Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Targeted-protein Degradation Therapeutics Segment by Type
  2.2.1 ARV-110
  2.2.2 ARV-471
  2.2.3 Other
2.3 Targeted-protein Degradation Therapeutics Market Size by Type
  2.3.1 Targeted-protein Degradation Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Targeted-protein Degradation Therapeutics Segment by Application
  2.4.1 Cancer
  2.4.2 Neuroscience
  2.4.3 Other
2.5 Targeted-protein Degradation Therapeutics Market Size by Application
  2.5.1 Targeted-protein Degradation Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2020-2025)

3 TARGETED-PROTEIN DEGRADATION THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Targeted-protein Degradation Therapeutics Market Size Market Share by Player
  3.1.1 Global Targeted-protein Degradation Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Targeted-protein Degradation Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Targeted-protein Degradation Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TARGETED-PROTEIN DEGRADATION THERAPEUTICS BY REGION

4.1 Targeted-protein Degradation Therapeutics Market Size by Region (2020-2025)
4.2 Global Targeted-protein Degradation Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Targeted-protein Degradation Therapeutics Market Size Growth (2020-2025)
4.4 APAC Targeted-protein Degradation Therapeutics Market Size Growth (2020-2025)
4.5 Europe Targeted-protein Degradation Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Targeted-protein Degradation Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Targeted-protein Degradation Therapeutics Market Size by Country (2020-2025)
5.2 Americas Targeted-protein Degradation Therapeutics Market Size by Type (2020-2025)
5.3 Americas Targeted-protein Degradation Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Targeted-protein Degradation Therapeutics Market Size by Region (2020-2025)
6.2 APAC Targeted-protein Degradation Therapeutics Market Size by Type (2020-2025)
6.3 APAC Targeted-protein Degradation Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Targeted-protein Degradation Therapeutics Market Size by Country (2020-2025)
7.2 Europe Targeted-protein Degradation Therapeutics Market Size by Type (2020-2025)
7.3 Europe Targeted-protein Degradation Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Targeted-protein Degradation Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Targeted-protein Degradation Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Targeted-protein Degradation Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TARGETED-PROTEIN DEGRADATION THERAPEUTICS MARKET FORECAST

10.1 Global Targeted-protein Degradation Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Targeted-protein Degradation Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Targeted-protein Degradation Therapeutics Forecast
  10.1.3 APAC Targeted-protein Degradation Therapeutics Forecast
  10.1.4 Europe Targeted-protein Degradation Therapeutics Forecast
  10.1.5 Middle East & Africa Targeted-protein Degradation Therapeutics Forecast
10.2 Americas Targeted-protein Degradation Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Targeted-protein Degradation Therapeutics Forecast
  10.2.2 Canada Market Targeted-protein Degradation Therapeutics Forecast
  10.2.3 Mexico Market Targeted-protein Degradation Therapeutics Forecast
  10.2.4 Brazil Market Targeted-protein Degradation Therapeutics Forecast
10.3 APAC Targeted-protein Degradation Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Targeted-protein Degradation Therapeutics Market Forecast
  10.3.2 Japan Market Targeted-protein Degradation Therapeutics Forecast
  10.3.3 Korea Market Targeted-protein Degradation Therapeutics Forecast
  10.3.4 Southeast Asia Market Targeted-protein Degradation Therapeutics Forecast
  10.3.5 India Market Targeted-protein Degradation Therapeutics Forecast
  10.3.6 Australia Market Targeted-protein Degradation Therapeutics Forecast
10.4 Europe Targeted-protein Degradation Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Targeted-protein Degradation Therapeutics Forecast
  10.4.2 France Market Targeted-protein Degradation Therapeutics Forecast
  10.4.3 UK Market Targeted-protein Degradation Therapeutics Forecast
  10.4.4 Italy Market Targeted-protein Degradation Therapeutics Forecast
  10.4.5 Russia Market Targeted-protein Degradation Therapeutics Forecast
10.5 Middle East & Africa Targeted-protein Degradation Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Targeted-protein Degradation Therapeutics Forecast
  10.5.2 South Africa Market Targeted-protein Degradation Therapeutics Forecast
  10.5.3 Israel Market Targeted-protein Degradation Therapeutics Forecast
  10.5.4 Turkey Market Targeted-protein Degradation Therapeutics Forecast
10.6 Global Targeted-protein Degradation Therapeutics Forecast by Type (2026-2031)
10.7 Global Targeted-protein Degradation Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Targeted-protein Degradation Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Arvinas
  11.1.1 Arvinas Company Information
  11.1.2 Arvinas Targeted-protein Degradation Therapeutics Product Offered
  11.1.3 Arvinas Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Arvinas Main Business Overview
  11.1.5 Arvinas Latest Developments
11.2 Nurix Therapeutics
  11.2.1 Nurix Therapeutics Company Information
  11.2.2 Nurix Therapeutics Targeted-protein Degradation Therapeutics Product Offered
  11.2.3 Nurix Therapeutics Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Nurix Therapeutics Main Business Overview
  11.2.5 Nurix Therapeutics Latest Developments
11.3 Kymera Therapeutics
  11.3.1 Kymera Therapeutics Company Information
  11.3.2 Kymera Therapeutics Targeted-protein Degradation Therapeutics Product Offered
  11.3.3 Kymera Therapeutics Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Kymera Therapeutics Main Business Overview
  11.3.5 Kymera Therapeutics Latest Developments
11.4 C4 Therapeutics
  11.4.1 C4 Therapeutics Company Information
  11.4.2 C4 Therapeutics Targeted-protein Degradation Therapeutics Product Offered
  11.4.3 C4 Therapeutics Targeted-protein Degradation Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 C4 Therapeutics Main Business Overview
  11.4.5 C4 Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Targeted-protein Degradation Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Targeted-protein Degradation Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of ARV-110
Table 4. Major Players of ARV-471
Table 5. Major Players of Other
Table 6. Targeted-protein Degradation Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Targeted-protein Degradation Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Targeted-protein Degradation Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Targeted-protein Degradation Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Targeted-protein Degradation Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Targeted-protein Degradation Therapeutics Key Players Head office and Products Offered
Table 15. Targeted-protein Degradation Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Targeted-protein Degradation Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Targeted-protein Degradation Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Targeted-protein Degradation Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Targeted-protein Degradation Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Targeted-protein Degradation Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Targeted-protein Degradation Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Targeted-protein Degradation Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Targeted-protein Degradation Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Targeted-protein Degradation Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Targeted-protein Degradation Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Targeted-protein Degradation Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Targeted-protein Degradation Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Targeted-protein Degradation Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Targeted-protein Degradation Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Targeted-protein Degradation Therapeutics
Table 40. Key Market Challenges & Risks of Targeted-protein Degradation Therapeutics
Table 41. Key Industry Trends of Targeted-protein Degradation Therapeutics
Table 42. Global Targeted-protein Degradation Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Targeted-protein Degradation Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Targeted-protein Degradation Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Targeted-protein Degradation Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Arvinas Details, Company Type, Targeted-protein Degradation Therapeutics Area Served and Its Competitors
Table 47. Arvinas Targeted-protein Degradation Therapeutics Product Offered
Table 48. Arvinas Targeted-protein Degradation Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Arvinas Main Business
Table 50. Arvinas Latest Developments
Table 51. Nurix Therapeutics Details, Company Type, Targeted-protein Degradation Therapeutics Area Served and Its Competitors
Table 52. Nurix Therapeutics Targeted-protein Degradation Therapeutics Product Offered
Table 53. Nurix Therapeutics Targeted-protein Degradation Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Nurix Therapeutics Main Business
Table 55. Nurix Therapeutics Latest Developments
Table 56. Kymera Therapeutics Details, Company Type, Targeted-protein Degradation Therapeutics Area Served and Its Competitors
Table 57. Kymera Therapeutics Targeted-protein Degradation Therapeutics Product Offered
Table 58. Kymera Therapeutics Targeted-protein Degradation Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Kymera Therapeutics Main Business
Table 60. Kymera Therapeutics Latest Developments
Table 61. C4 Therapeutics Details, Company Type, Targeted-protein Degradation Therapeutics Area Served and Its Competitors
Table 62. C4 Therapeutics Targeted-protein Degradation Therapeutics Product Offered
Table 63. C4 Therapeutics Targeted-protein Degradation Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. C4 Therapeutics Main Business
Table 65. C4 Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Targeted-protein Degradation Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Targeted-protein Degradation Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Targeted-protein Degradation Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Targeted-protein Degradation Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Type in 2024
Figure 10. Targeted-protein Degradation Therapeutics in Cancer
Figure 11. Global Targeted-protein Degradation Therapeutics Market: Cancer (2020-2025) & ($ millions)
Figure 12. Targeted-protein Degradation Therapeutics in Neuroscience
Figure 13. Global Targeted-protein Degradation Therapeutics Market: Neuroscience (2020-2025) & ($ millions)
Figure 14. Targeted-protein Degradation Therapeutics in Other
Figure 15. Global Targeted-protein Degradation Therapeutics Market: Other (2020-2025) & ($ millions)
Figure 16. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Targeted-protein Degradation Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Targeted-protein Degradation Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Targeted-protein Degradation Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Targeted-protein Degradation Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Targeted-protein Degradation Therapeutics Value Market Share by Country in 2024
Figure 24. United States Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Targeted-protein Degradation Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Targeted-protein Degradation Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Targeted-protein Degradation Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Targeted-protein Degradation Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Targeted-protein Degradation Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Targeted-protein Degradation Therapeutics Market Size 2026-2031 ($ millions)